azathioprine has been researched along with Acantholysis Bullosa in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furue, M | 1 |
Iwata, M | 1 |
Yoon, HI | 1 |
Kubota, Y | 1 |
Ohto, H | 1 |
Kawashima, M | 1 |
Tsuchida, T | 1 |
Oohara, K | 1 |
Tamaki, K | 1 |
Kukita, A | 1 |
1 other study available for azathioprine and Acantholysis Bullosa
Article | Year |
---|---|
Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer.
Topics: Autoantibodies; Azathioprine; Basement Membrane; Betamethasone; Cyclophosphamide; Dapsone; Epidermol | 1986 |